Powered by

Neuronetics Reports Second Quarter 2019 Financial and Operating Results

Aug 06, 2019 - GlobeNewswire

MALVERN, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the second quarter of 2019.

Second Quarter 2019 Highlights

Second quarter 2019 revenue of $16.6 million, an increase of 25% over the second quarter of 2018Second...